This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lattuada, D. Articles by Di Blasio, A. M. Search for Related Content PubMed PubMed Citation Articles by Lattuada, D. Articles by Di Blasio, A. M.

Accumulation of Retinoid X Receptor- in Uterine Leiomyomas Is Associated with a Delayed Ligand-Dependent Proteasome-Mediated Degradation and an Alteration of Its Transcriptional Activity

Department of Obstetrics, Gynaecology and Neonatology (D.L., P.V., S.M., S.D.), Fondazione Policlinico-Mangiagalli-Regina Elena Hospital and University of Milan, 20122 Milano, Italy; Department of Obstetrics and Gynecology (M.V.), Clinica Macedonio Melloni and University of Milan, 20129 Milano, Italy; and Molecular Biology Laboratory (J.S., A.M.D), Istituto Auxologico Italiano, 20095 Cusano Milanino, Italy

Address all correspondence and requests for reprints to: Dr. Anna Maria Di Blasio, Molecular Biology Laboratory, Istituto Auxologico Italiano, Via Zucchi 18, 20095 Cusano Milanino, Italy. E-mail: a.diblasio{at}auxologico.it.

An alteration of the retinoid pathway can influence the development of uterine leiomyomas in animal models, and retinoids have shown efficacy in inhibiting the growth of this benign tumor both in vitro and in vivo. However, the underlying mechanisms and biological implications are unclear. The present study was based on the demonstration of an accumulation of full-length retinoid X receptor (RXR) in leiomyomas that was not associated with a modification of its gene expression. This accumulation was shown to increase the transcription of the RXR-responsive gene cellular retinoic acid binding protein II (CRABP-II) and to be linked to the cellular redistribution of the receptor and to its retarded degradation via the ubiquitin/proteasome pathway. Accordingly, treatment with a specific proteasome inhibitor but not with protease inhibitors strongly inhibited the degradation of full-length RXR in cells deriving from both myometrium and leiomyoma, but the formation of RXR/ubiquitin conjugates was differentially regulated between the two cell types. Moreover, full-length RXR accumulated in leiomyomas was abnormally phosphorylated at serine/threonine residues relative to myometrial tissue. The ligand to RXR, 9-cis-retinoic acid, induced the receptor breakdown in smooth muscle cells deriving from both normal and tumor tissue, whereas a MAPK-specific inhibitor was able to reduce RXR levels only in leiomyoma cells. These results suggest that switching of the ubiquitin/proteasome-dependent degradation of RXR by phosphorylation in leiomyomas may be responsible for the accumulation of the receptor and the consequent dysregulation of retinoic acid target genes. The ability of retinoids to modify this molecular alteration may be the rationale for their use in the treatment of leiomyomas.

NURSA Molecule Pages Link:

Nuclear Receptors:   RXRα

Coregulators:   CRABPII

Ligands:   9-cis-Retinoic acid

This article has been cited by other articles:

				M. Zaitseva, B. J. Vollenhoven, and P. A.W. Rogers Retinoids regulate genes involved in retinoic acid synthesis and transport in human myometrial and fibroid smooth muscle cells Hum. Reprod., May 1, 2008; 23(5): 1076 - 1086. [Abstract] [Full Text] [PDF]

				M. Zaitseva, B. J. Vollenhoven, and P. A.W. Rogers Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium Mol. Hum. Reprod., August 1, 2007; 13(8): 577 - 585. [Abstract] [Full Text] [PDF]